Cargando…
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes
Immunotherapies harnessing T cell immunity have shown remarkable clinical success for the management of cancer. However, only a proportion of patients benefit from these treatments. The presence of type I interferon (IFN) within the tumor microenvironment is critical for driving effective tumor-spec...
Autores principales: | Buzzai, Anthony C., Wagner, Teagan, Audsley, Katherine M., Newnes, Hannah V., Barrett, Lucy W., Barnes, Samantha, Wylie, Ben C., Stone, Shane, McDonnell, Alison, Fear, Vanessa S., Foley, Bree, Waithman, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145903/ https://www.ncbi.nlm.nih.gov/pubmed/32308653 http://dx.doi.org/10.3389/fimmu.2020.00542 |
Ejemplares similares
-
IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
por: Audsley, Katherine M., et al.
Publicado: (2021) -
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells
por: Barrett, Lucy W, et al.
Publicado: (2022) -
Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
por: Barnes, Samantha A., et al.
Publicado: (2022) -
CD8(+)XCR1(neg) Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors
por: Wylie, Ben, et al.
Publicado: (2019) -
Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)